Chronic Prostatitis Collaborative Clinical Trials

慢性前列腺炎协作临床试验

基本信息

项目摘要

DESCRIPTION (provided by applicant): This application reflects a proposal from the Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH) / Harvard Medical School to become one of the Clinical Centers of the Chronic Prostatitis Collaborative Research Network (CPCRN) to develop and conduct randomized clinical trials for evaluating novel therapies in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). The BWH/MGH Harvard clinical center has a history of successful recruitment and retention of CP/CPPS patients, including a substantial proportion of Latino patients, from the New England area for CPCRN 1997- 2003 - both for the Chronic Prostatitis Cohort Study and Randomized Clinical Trial. Drs. Mary McNaughton Collins and Michael O'Leary have advanced the field of CP/CPPS by helping to develop and validate the NIH-Chronic Prostatitis Symptom Index, translating the index to Spanish, evaluating the quality of life and resource utilization of men with CP/CPPS, as well as examining the epidemiology and natural history of the condition. Dr. McNaughton Collins has also performed several chronic prostatitis studies as a member of the Patient Outcomes Research Team (PORT) for Prostate Diseases and the Cochrane Collaboration. The BWH/MGH Harvard clinical center has expanded to include a multi-institutional and multi-disciplinary network of co-investigators and consultants with both content (i.e., chronic prostatitis, pain management) expertise and methodological (i.e., clinical trials, basic science, and outcomes research) training, as well as fresh sources of chronic prostatitis patients, especially newly diagnosed patients and minority patients. The new reservoirs of CP/CPPS patients include: 1) newly diagnosed CP/CPPS patients from primary care practices and medical walk-in units across the two large institutions and their neighborhood health centers, including the BWH internal medicine Spanish clinic; 2) both newly diagnosed and long-term CP/CPPS patients from the MGH Spanish urology clinic, and; 3) both newly diagnosed and long-term patients from Boston Medical Center, which is a large, inner-city academic health center providing care to a large proportion of African American patients. To assist in the recruitment and retention of Latino men, the site now includes 3 Spanish speaking medicine and urology investigators, and the Research Coordinator is taking Spanish classes to become proficient. This proposal includes a clinical trial design for consideration by the CPCRN. The multi-institutional, multi-disciplinary team from the BWH/MGH Harvard clinical center is eager to collaborate on treatment trials and ancillary studies with other CPCRN centers, the NIH/NIDDK scientific team, and the Interstitial Cystitis Clinical Trials Group.
描述(由申请人提供): 这项申请反映了布里根妇女医院(BWH)和马萨诸塞州综合医院(MGH)/哈佛医学院提出的一项建议,即成为慢性前列腺炎合作研究网络(CPCRN)的临床中心之一,以开发和进行随机临床试验,评估慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)患者的新疗法。BWH/MGH哈佛临床中心有成功招募和留住新英格兰地区CP/CPPS患者的历史,包括相当大比例的拉丁裔患者,用于1997-2003年的CPCRN-慢性前列腺炎队列研究和随机临床试验。Mary McNaughton Collins博士和Michael O‘Leary博士通过帮助开发和验证NIH-慢性前列腺炎症状指数,将该指数翻译成西班牙语,评估患有CP/CPPS的男性的生活质量和资源利用,以及检查这种疾病的流行病学和自然病史,推动了CP/CPPS领域的发展。麦克诺顿·柯林斯博士还作为前列腺病患者结局研究小组(PORT)和Cochrane合作小组的成员进行了几项慢性前列腺炎研究。BWH/MGH哈佛临床中心已经扩大到包括一个多机构和多学科的合作研究和顾问网络,包括内容(即慢性前列腺炎、疼痛管理)专业知识和方法(即临床试验、基础科学和结果研究)培训,以及慢性前列腺炎患者的新来源,特别是新诊断的患者和少数族裔患者。新的CP/CPPS患者库包括:1)来自两大机构及其邻近卫生中心(包括BWH内科西班牙诊所)的初级保健诊所和医疗机构的新诊断CP/CPPS患者;2)来自MGH西班牙泌尿外科诊所的新诊断和长期CP/CPPS患者;以及3)来自波士顿医疗中心的新诊断和长期患者,该中心是一家大型市中心学术医疗中心,为大部分非裔美国人患者提供护理。为了帮助招募和留住拉美裔男性,该网站现在包括3名会说西班牙语的医学和泌尿科调查人员,研究协调员正在上西班牙语课程,以掌握熟练程度。该建议包括一项临床试验设计,供CPCRN审议。来自BWH/MGH哈佛临床中心的多机构、多学科团队渴望与其他CPCRN中心、NIH/NIDDK科学团队和间质性膀胱炎临床试验小组在治疗试验和辅助研究方面进行合作。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY F MCNAUGHTON-COLLINS其他文献

MARY F MCNAUGHTON-COLLINS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY F MCNAUGHTON-COLLINS', 18)}}的其他基金

Chronic Prostatitis Collaborative Clinical Trials
慢性前列腺炎协作临床试验
  • 批准号:
    6948130
  • 财政年份:
    2003
  • 资助金额:
    $ 25万
  • 项目类别:
Chronic Prostatitis Collaborative Clinical Trials
慢性前列腺炎协作临床试验
  • 批准号:
    7037438
  • 财政年份:
    2003
  • 资助金额:
    $ 25万
  • 项目类别:
Chronic Prostatitis Collaborative Clinical Trials
慢性前列腺炎协作临床试验
  • 批准号:
    7070952
  • 财政年份:
    2003
  • 资助金额:
    $ 25万
  • 项目类别:
Chronic Prostatitis Collaborative Clinical Trials
慢性前列腺炎协作临床试验
  • 批准号:
    7252168
  • 财政年份:
    2003
  • 资助金额:
    $ 25万
  • 项目类别:
Chronic Prostatitis Collaborative Clinical Trials
慢性前列腺炎协作临床试验
  • 批准号:
    7415363
  • 财政年份:
    2003
  • 资助金额:
    $ 25万
  • 项目类别:
Chronic Prostatitis Collaborative Clinical Trials
慢性前列腺炎协作临床试验
  • 批准号:
    6683063
  • 财政年份:
    2003
  • 资助金额:
    $ 25万
  • 项目类别:
Chronic Prostatitis Collaborative Clinical Trials
慢性前列腺炎协作临床试验
  • 批准号:
    7413890
  • 财政年份:
    2003
  • 资助金额:
    $ 25万
  • 项目类别:
Chronic Prostatitis Collaborative Clinical Trials
慢性前列腺炎协作临床试验
  • 批准号:
    7235695
  • 财政年份:
    2003
  • 资助金额:
    $ 25万
  • 项目类别:
Chronic Prostatitis Collaborative Clinical Trials
慢性前列腺炎协作临床试验
  • 批准号:
    6873012
  • 财政年份:
    2003
  • 资助金额:
    $ 25万
  • 项目类别:

相似海外基金

Cannabinoid Acids as Antiinflammatory Agents
大麻素酸作为抗炎剂
  • 批准号:
    6665391
  • 财政年份:
    2002
  • 资助金额:
    $ 25万
  • 项目类别:
Cannabinoid Acids as Antiinflammatory Agents
大麻素酸作为抗炎剂
  • 批准号:
    6797921
  • 财政年份:
    2002
  • 资助金额:
    $ 25万
  • 项目类别:
New Antiinflammatory Agents to Prevent Damage to Islets
防止胰岛损伤的新型抗炎剂
  • 批准号:
    6576060
  • 财政年份:
    2002
  • 资助金额:
    $ 25万
  • 项目类别:
Cannabinoid Acids as Antiinflammatory Agents
大麻素酸作为抗炎剂
  • 批准号:
    6573795
  • 财政年份:
    2002
  • 资助金额:
    $ 25万
  • 项目类别:
New Antiinflammatory Agents to Prevent Damage to Islets
防止胰岛损伤的新型抗炎剂
  • 批准号:
    6665374
  • 财政年份:
    2002
  • 资助金额:
    $ 25万
  • 项目类别:
Effects of nonsteroidal antiinflammatory agents on thyroid hormone levels
非甾体抗炎药对甲状腺激素水平的影响
  • 批准号:
    6465857
  • 财政年份:
    2000
  • 资助金额:
    $ 25万
  • 项目类别:
ROLE OF NONSTEROIDAL ANTIINFLAMMATORY AGENTS IN OUTCOME OF OA
非甾体类抗炎药在 OA 结局中的作用
  • 批准号:
    6318272
  • 财政年份:
    2000
  • 资助金额:
    $ 25万
  • 项目类别:
CARIBBEAN CORALS (PSEUDOPTEROGORIA) AS SOURCE OF NEW ANTIINFLAMMATORY AGENTS)
加勒比珊瑚(PSEUDOPTEROGORIA)作为新型抗炎剂的来源)
  • 批准号:
    6219061
  • 财政年份:
    1999
  • 资助金额:
    $ 25万
  • 项目类别:
ROLE OF NONSTEROIDAL ANTIINFLAMMATORY AGENTS IN OUTCOME OF OA
非甾体类抗炎药在 OA 结局中的作用
  • 批准号:
    6100638
  • 财政年份:
    1999
  • 资助金额:
    $ 25万
  • 项目类别:
CARIBBEAN CORALS (PSEUDOPTEROGORIA) AS SOURCE OF NEW ANTIINFLAMMATORY AGENTS)
加勒比珊瑚(PSEUDOPTEROGORIA)作为新型抗炎剂的来源)
  • 批准号:
    6107139
  • 财政年份:
    1998
  • 资助金额:
    $ 25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了